US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 11.220
  • -0.220-1.92%
Close Mar 21 16:00 ET
  • 11.220
  • 0.0000.00%
Post 16:39 ET
455.11MMarket Cap-2.24P/E (TTM)

Keros Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
-38.13%-33.98M
-36.49%-30.83M
-2,299.09%-34.24M
Net income from continuing operations
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
Operating gains losses
----
----
----
----
----
-66.67%4K
--0
--0
--0
--4K
Depreciation and amortization
50.80%1.23M
34.41%332K
49.52%314K
60.21%306K
65.87%277K
20.92%815K
94.49%247K
66.67%210K
-37.99%191K
47.79%167K
Other non cash items
17.27%1.82M
70.75%572K
65.10%563K
-2.26%346K
-35.06%339K
64.93%1.55M
4.36%335K
61.61%341K
71.84%354K
157.14%522K
Change In working capital
-331.58%-11.44M
-246.64%-10.09M
435.49%12.76M
-336.04%-3.98M
-110.60%-10.13M
-118.52%-2.65M
123.31%6.88M
38.60%-3.8M
-44.46%-913K
-126.65%-4.81M
-Change in receivables
-1,717.48%-2.6M
-1,546.15%-2.35M
---384K
--222K
---83K
-100.79%-143K
---143K
--0
--0
--0
-Change in prepaid assets
-10.05%-10.22M
-1,073.28%-5.25M
237.86%5.87M
-327.54%-6.37M
-9.92%-4.48M
-179.55%-9.28M
299.63%539K
-1,584.32%-4.26M
63.70%-1.49M
-633.25%-4.07M
-Change in payables and accrued expense
-60.66%2.7M
-123.31%-1.59M
7,631.52%7.11M
316.75%2.51M
-713.89%-5.33M
39.82%6.87M
40.61%6.83M
102.48%92K
-85.21%603K
-113.36%-655K
-Change in other current assets
99.16%-4K
1.88%-469K
--491K
----
----
69.63%-478K
---478K
--0
----
----
-Change in other working capital
-443.75%-1.32M
-429.46%-425K
-190.93%-331K
-1,100.00%-324K
-192.68%-240K
110.35%384K
108.55%129K
130.46%364K
95.54%-27K
79.60%-82K
Cash from discontinued investing activities
Operating cash flow
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
-38.13%-33.98M
-36.49%-30.83M
-2,299.09%-34.24M
Investing cash flow
Cash flow from continuing investing activities
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
Net PPE purchase and sale
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
Cash from discontinued investing activities
Investing cash flow
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
Financing cash flow
Cash flow from continuing financing activities
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
-99.42%284K
-82.93%1.74M
91,152.54%107.68M
Net common stock issuance
116.20%380.13M
6.69%73.1M
--155.07M
--629K
41.03%151.34M
47.04%175.83M
11.59%68.52M
--0
--0
--107.31M
Proceeds from stock option exercised by employees
276.47%12.14M
204.10%2.45M
224.12%1.01M
70.52%2.97M
1,446.22%5.72M
294.25%3.23M
688.24%804K
223.96%311K
246.61%1.74M
213.56%370K
Net other financing activities
-382.98%-454K
--0
---130K
---65K
---259K
-8.05%-94K
---67K
----
----
----
Cash from discontinued financing activities
Financing cash flow
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
-99.42%284K
-82.93%1.74M
91,152.54%107.68M
Net cash flow
Beginning cash position
18.54%332.36M
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
21.18%280.38M
20.08%289.11M
49.05%323.35M
53.43%352.76M
21.18%280.38M
Current changes in cash
340.56%229.02M
-32.38%29.25M
465.15%125.06M
-24.41%-36.58M
53.76%111.3M
6.08%51.98M
9.17%43.25M
-243.87%-34.25M
-126.79%-29.4M
5,071.22%72.38M
End cash Position
68.91%561.38M
68.91%561.38M
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
18.54%332.36M
20.08%289.11M
49.05%323.35M
53.43%352.76M
Free cash flow
-28.22%-162.8M
-78.07%-46.3M
10.56%-30.89M
-28.80%-40.11M
-28.92%-45.51M
-78.07%-126.97M
-19.30%-26M
-39.37%-34.53M
-34.49%-31.14M
-2,142.50%-35.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M-38.13%-33.98M-36.49%-30.83M-2,299.09%-34.24M
Net income from continuing operations -22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M
Operating gains losses ---------------------66.67%4K--0--0--0--4K
Depreciation and amortization 50.80%1.23M34.41%332K49.52%314K60.21%306K65.87%277K20.92%815K94.49%247K66.67%210K-37.99%191K47.79%167K
Other non cash items 17.27%1.82M70.75%572K65.10%563K-2.26%346K-35.06%339K64.93%1.55M4.36%335K61.61%341K71.84%354K157.14%522K
Change In working capital -331.58%-11.44M-246.64%-10.09M435.49%12.76M-336.04%-3.98M-110.60%-10.13M-118.52%-2.65M123.31%6.88M38.60%-3.8M-44.46%-913K-126.65%-4.81M
-Change in receivables -1,717.48%-2.6M-1,546.15%-2.35M---384K--222K---83K-100.79%-143K---143K--0--0--0
-Change in prepaid assets -10.05%-10.22M-1,073.28%-5.25M237.86%5.87M-327.54%-6.37M-9.92%-4.48M-179.55%-9.28M299.63%539K-1,584.32%-4.26M63.70%-1.49M-633.25%-4.07M
-Change in payables and accrued expense -60.66%2.7M-123.31%-1.59M7,631.52%7.11M316.75%2.51M-713.89%-5.33M39.82%6.87M40.61%6.83M102.48%92K-85.21%603K-113.36%-655K
-Change in other current assets 99.16%-4K1.88%-469K--491K--------69.63%-478K---478K--0--------
-Change in other working capital -443.75%-1.32M-429.46%-425K-190.93%-331K-1,100.00%-324K-192.68%-240K110.35%384K108.55%129K130.46%364K95.54%-27K79.60%-82K
Cash from discontinued investing activities
Operating cash flow -29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M-38.13%-33.98M-36.49%-30.83M-2,299.09%-34.24M
Investing cash flow
Cash flow from continuing investing activities 21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M
Net PPE purchase and sale 21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M
Cash from discontinued investing activities
Investing cash flow 21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M
Financing cash flow
Cash flow from continuing financing activities 118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M-99.42%284K-82.93%1.74M91,152.54%107.68M
Net common stock issuance 116.20%380.13M6.69%73.1M--155.07M--629K41.03%151.34M47.04%175.83M11.59%68.52M--0--0--107.31M
Proceeds from stock option exercised by employees 276.47%12.14M204.10%2.45M224.12%1.01M70.52%2.97M1,446.22%5.72M294.25%3.23M688.24%804K223.96%311K246.61%1.74M213.56%370K
Net other financing activities -382.98%-454K--0---130K---65K---259K-8.05%-94K---67K------------
Cash from discontinued financing activities
Financing cash flow 118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M-99.42%284K-82.93%1.74M91,152.54%107.68M
Net cash flow
Beginning cash position 18.54%332.36M84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M21.18%280.38M20.08%289.11M49.05%323.35M53.43%352.76M21.18%280.38M
Current changes in cash 340.56%229.02M-32.38%29.25M465.15%125.06M-24.41%-36.58M53.76%111.3M6.08%51.98M9.17%43.25M-243.87%-34.25M-126.79%-29.4M5,071.22%72.38M
End cash Position 68.91%561.38M68.91%561.38M84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M18.54%332.36M20.08%289.11M49.05%323.35M53.43%352.76M
Free cash flow -28.22%-162.8M-78.07%-46.3M10.56%-30.89M-28.80%-40.11M-28.92%-45.51M-78.07%-126.97M-19.30%-26M-39.37%-34.53M-34.49%-31.14M-2,142.50%-35.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.